{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:44:53Z","timestamp":1790390693392,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ijid.2020.12.024","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T02:33:11Z","timestamp":1607999591000},"page":"549-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9665-7853","authenticated-orcid":false,"given":"Snigdha","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7020-7777","authenticated-orcid":false,"given":"Ananta","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitha","family":"B","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-3406","authenticated-orcid":false,"given":"Kabir","family":"Sardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aastha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-2588","authenticated-orcid":false,"given":"Aishwarya","family":"Muddebihal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Raina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purnima","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.12.024_bib0005","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.39031","article-title":"Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis","volume":"67","author":"Cribbs","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.ijid.2020.12.024_bib0010","article-title":"Dexamethasone in Hospitalized Patients with Covid-19 \u2014 Preliminary Report","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2020.12.024_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116935","article-title":"Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced \u2018PANIC\u201911Prolific Activation of a Network Immune-Inflammatory Crisis [PANIC]. attack","volume":"415","author":"Frohman","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ijid.2020.12.024_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.06.999","article-title":"Risk of COVID-19 in Dermatologic Patients on Long-term Immunomodulatory Therapy","author":"Holcomb","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2020.12.024_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13639","article-title":"Immunosuppressive agents for dermatological indications in the ongoing COVID-19 pandemic: Rationalizing use and clinical applicability","author":"Khurana","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ijid.2020.12.024_bib0030","series-title":"Jopling\u2019s Handbook of Leprosy","first-page":"182","article-title":"Immunopathology of reactions","author":"Khurana","year":"2020"},{"key":"10.1016\/j.ijid.2020.12.024_bib0035","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.23913","article-title":"Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis","volume":"59","author":"Lacaille","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijid.2020.12.024_bib0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.2002.01791.x","article-title":"High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy","volume":"128","author":"Manandhar","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ijid.2020.12.024_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108576","article-title":"Interferon gamma, TGF-\u03b21 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients","volume":"220","author":"Montalvo Villalba","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijid.2020.12.024_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","volume":"79","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2020.12.024_bib0055","series-title":"Jopling\u2019s Handbook of Leprosy","first-page":"211","article-title":"Type 2 Lepra Reaction","author":"Narang","year":"2020"},{"key":"10.1016\/j.ijid.2020.12.024_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101670","article-title":"Use of methotrexate for leprosy reactions. Experience of a referral center and systematic review of the literature","author":"Perez-Molina","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijid.2020.12.024_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116942","article-title":"Silencing of immune activation with methotrexate in patients with COVID-19","volume":"415","author":"Safavi","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ijid.2020.12.024_bib0070","series-title":"Systemic Drugs in Dermatology","first-page":"304","article-title":"Immunosuppressive drugs","author":"Sekhri","year":"2016"},{"key":"10.1016\/j.ijid.2020.12.024_bib0075","first-page":"10","article-title":"Leprosy reactions--complications of steroid therapy","volume":"66","author":"Sugumaran","year":"1998","journal-title":"Int J Lepr Other Mycobact Dis Off Organ Int Lepr Assoc"},{"key":"10.1016\/j.ijid.2020.12.024_bib0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ard.53.4.224","article-title":"Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate","volume":"53","author":"van der Veen","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2020.12.024_bib0085","doi-asserted-by":"crossref","first-page":"e2440","DOI":"10.1371\/journal.pntd.0002440","article-title":"A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction","volume":"7","author":"Voorend","year":"2013","journal-title":"PLoS Negl Trop Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220325479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220325479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:00:26Z","timestamp":1761120026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220325479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":17,"alternative-id":["S1201971220325479"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.12.024","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}